28家药企涉商业贿赂案!多起医药虚假宣传曝光,大联盟集采中选结果出炉,恒瑞、乐普大爆发

米内网
Yesterday

看点view本周,2025年国谈开启,第十一批国采272家企业的453个产品拟中选,医药反腐再掀风暴,多起医药虚假宣传典型案例曝光。市场迎变局,大联盟集采中选结果出炉,第四批鼓励仿制药品建议目录公示;研发新进展,信达、恒瑞、乐普创新药大爆发;企业新资讯,多位医药人上榜2025胡润百富榜,“稻米造血”登陆科创板,九芝堂进军多肽原料药领域……医药行业一周大事件,精彩不容错过!米内一周TOP榜米内数据...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10